Meet the Fund Manager
Matt McNamara Board Director & CIOHorizon 3 Biotech
Meet the Manager
Get access to some of Australia’s leading fund managers who share their 3 favourite stocks, investment approach and insights on the market.
Each session includes:
- 3 favourite stock opportunities
- Market views for the year ahead
- Investment strategy and approaches
This is a live and interactive online session, and participants are encouraged to ask questions. Joining only requires an internet connection. Spots are limited, so secure yours today.
Horizon 3 Biotech, is a biotech venture capital company seeking to capitalise on opportunities presented by emerging therapeutic and medical device companies, and the low level of investment competition in the segment. The company manages the Horizon 3 Biotech Fund, a wholesale unit trust targeting $100 million in funding and a gross return of 20% per annum using an approach that hits key inflection points faster while limiting downside and increasing the upside. Matt McNamara has more than 30 years in healthcare and medical sciences and more than 20 years’ experience as a venture capitalist. His business acumen and strong background in the life sciences sector make him one of the industry’s most credible investment voices.
Robert Calnon OC Funds Management
Hear about OC Funds Management, whose microcap fund was recently crowned Australia’s best-performing microcap fund by Morningstar (total return over five years). Robert Calnon, one of OC’s three highly experienced portfolio managers, shares his smallcap investing insights with us.
Matt McNamara Horizon 3 Biotech
Matt is a specialist in human healthcare technology and is passionate about investing in the commercialisation of this industry. He has spent more than 30 years in the healthcare and medical sciences sector and has more than 20 years’ experience as a venture capitalist. His business acumen and strong background in the life sciences sector make him one of the industry’s most credible investment voices.
David Keelan & Alexandra Clarke Ellerston Capital
Alexandra has worked in the finance market for 11 years and has extensive market IPO and pre-IPO experience. She provides in-depth research and analysis of stocks that range from micro to large caps covering the Industrial sector. David is a specialist investment manager with a distinctive approach to portfolio construction and investment selection.